Ocular Therapeutix Inc (NASDAQ:OCUL)

4.13
Delayed Data
As of Sep 28
 -0.185 / -4.29%
Today’s Change
2.91
Today|||52-Week Range
12.50
-40.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.8M1.9M1.9M2.0M
 
 
 
 
 
Cost of Goods Sold319.0K2.5K457.0K465.0K
 
 
 
 
 
Depreciation And Amortization754.0K881.0K1.6M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income677.0K1.0M-159.0K-761.0K
 
 
 
 
 
General Expenses38.9M44.3M59.3M58.4M
 
 
 
 
 
Research And Development26.6M27.1M30.2M36.9M
 
 
 
 
 
Total Operating Expenses39.9M45.2M61.3M61.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.2M-43.3M-59.4M-59.1M
 
 
 
 
 
Extraordinary Charge0.000.00-2.5M0.00
 
 
Interest Expense On Debt1.7M1.7M1.9M1.7M
 
 
 
 
 
Other Expenses7.0K-1.0K5.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.7M-44.7M-63.4M-60.0M
 
 
 
 
 
Net Income-39.7M-44.7M-63.4M-60.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.2M24.8M28.8M38.1M
 
 
 
 
 
Shares To Calculate EPS Diluted23.2M24.8M28.8M38.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.71-$1.80-$2.20-$1.57
 
 
 
 
 
EPS Diluted-$1.71-$1.80-$2.20-$1.57